Magellan-1, Part 2: Glecaprevir and Pibrentasvir for 12 or 16 Weeks in Patients with Chronic Hcv Genotype 1 or 4 and Prior Direct-Acting Antiviral Treatment Failure
Journal of Virus Eradication（2017）
Key words
Treatment
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined